November 2025 in “Dermatological Reviews” Eyebrow mesotherapy improves eyebrow appearance and boosts confidence and mood.
November 2025 in “SKIN The Journal of Cutaneous Medicine” Low-level light therapy safely increases hair growth in various types of hair loss.
November 2025 in “JAAD Case Reports” Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.
November 2025 in “International Journal of Molecular Sciences” Combining different drugs can improve hair loss treatment.
November 2025 in “Journal of Investigative Dermatology” IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.
October 2025 in “Archives of Dermatological Research” Topical metformin gel is as effective and safe as steroids for treating alopecia areata.
September 2025 in “International Journal of Innovative Technologies in Social Science” Aesthetic gynecology improves women's intimate health and well-being with safe procedures but needs more research and standardized protocols.
September 2025 in “International Journal of Women’s Dermatology” Oral spironolactone effectively promotes hair growth in premenopausal women but may cause irregular menstruation.
September 2025 in “Journal of Dermatology Research” Sebamed® shampoo effectively reduces hair loss and promotes hair growth.
September 2025 in “Editora Pasteur eBooks” Low-dose oral minoxidil is as effective as or better than topical minoxidil for hair growth but may cause mild side effects.
September 2025 in “Clinical Cosmetic and Investigational Dermatology” Kūlaris improved quality of life for acne sufferers without side effects.
August 2025 in “Journal of Cosmetic Dermatology” Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.
August 2025 in “JAAD International” Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.
August 2025 in “Journal of Cosmetic Dermatology” The dietary supplement AGA-P improves the effectiveness of hair loss treatments.
August 2025 in “Skin Appendage Disorders” TCM is an effective and safe treatment for primary cicatricial alopecias.
August 2025 in “Archives of Dermatological Research” Oral minoxidil is more effective than topical minoxidil for hair growth in men.
Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.
BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.
August 2025 in “Galen Medical Journal” Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.
The supplement improved hair growth and reduced hair loss in women.
July 2025 in “Journal of Investigative Dermatology” AMP-303 safely increases hair growth in men with hair loss.
July 2025 in “The Journal of Dermatology” 5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.
The treatment with Bakuchiol and Neem oil significantly improved hair growth and was well-received by most participants.
July 2025 in “International Journal of Pharmacognosy and Pharmaceutical Sciences” Safer, alternative therapies like herbal treatments and lifestyle changes are needed for acne.
June 2025 in “The Journal of Dermatology” Baricitinib is effective and safe for long-term treatment of severe alopecia areata.
May 2025 in “Journal of Ayurveda and Integrated Medical Sciences” Vedistry Amla + Tablets improve hair health and are safe to use.
May 2025 in “Journal of Pharmacy And Bioallied Sciences” Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.
May 2025 in “UNESP Institutional Repository (São Paulo State University)” The 5 mg dose of oral minoxidil is not more effective than the 2.5 mg dose for treating male hair loss.
Exosome therapy successfully regrew and restored natural hair color in a man with stress-related hair loss.
May 2025 in “Journal of Inflammation Research” A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.